Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published November 4, 2013 | Accepted Version
Journal Article Open

Tailored Glycopolymers as Anticoagulant Heparin Mimetics

Abstract

Not to clot: Heparin and its low-molecular-weight derivatives are clinical therapeutics used to treat and prevent blood clots. The synthesis of heparin-based glycopolymers that are potent and potentially safer mimetics of heparin is described. The mimetics exhibited activity against proteases (FXa and FIIa) in the coagulation cascade and prolonged blood clot times in human plasma with efficacies similar to those of clinical anticoagulants. ATIII=antithrombin III.

Additional Information

© 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. Received: August 8, 2013; Published online: October 9, 2013. We thank Prof. Robert H. Grubbs and Dr. Jean Li for their generous donation of the ruthenium catalyst and for helpful discussions. This research was supported by National Institutes of Health grant R01 GM093627 (L.H.W.).

Attached Files

Accepted Version - nihms534450.pdf

Files

nihms534450.pdf
Files (1.2 MB)
Name Size Download all
md5:b3dff6b3a2a84a0e1b781849ea03bc1a
1.2 MB Preview Download

Additional details

Created:
August 22, 2023
Modified:
October 25, 2023